<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Enhanced Vision &#187; treatment</title>
	<atom:link href="http://www.enhancedvision.com/tag/treatment/feed" rel="self" type="application/rss+xml" />
	<link>http://www.enhancedvision.com</link>
	<description>Tagline</description>
	<lastBuildDate>Wed, 01 Sep 2010 23:15:39 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>FDA Approves Allergan, Anti-Blindness Drug</title>
		<link>http://www.enhancedvision.com/educational/fda-approves-allergan-anti-blindness-drug.html</link>
		<comments>http://www.enhancedvision.com/educational/fda-approves-allergan-anti-blindness-drug.html#comments</comments>
		<pubDate>Thu, 18 Jun 2009 22:45:55 +0000</pubDate>
		<dc:creator>Low Vision Blogger</dc:creator>
				<category><![CDATA[Educational]]></category>
		<category><![CDATA[allergan]]></category>
		<category><![CDATA[anti-sight]]></category>
		<category><![CDATA[approval]]></category>
		<category><![CDATA[blindness]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[macular edema]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.enhancedvision.com/low-vision-blog/?p=175</guid>
		<description><![CDATA[Allergan Inc. said today, June 18th, 2009, that the Food and Drug Administration approved a drug it developed to treat macular edema, a condition that can cause loss of central vision. Irvine-based Allergan says the drug, trade-named Ozurdex, is the first and only drug therapy approved for treating macular edema associated with retinal vein occlusion, the [...]]]></description>
		<wfw:commentRss>http://www.enhancedvision.com/educational/fda-approves-allergan-anti-blindness-drug.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
